Dr. Reddy's Laboratories Ltd | NYSE: RDY | Currency: USD | Type: ADR
Key Statistics
About Dr. Reddy's Laboratories Ltd
Dr. Reddy's Laboratories trades on the NYSE as an ADR under the ticker RDY, representing India's prominent generics and biosimilars maker. The US is the company's largest market, so FDA approvals, plant inspections and US generic-pricing trends move the receipt directly. The ADR gives international healthcare investors direct dollar exposure to Indian pharma.
Instrument Details
| Issuer | Dr. Reddy's Laboratories Ltd |
| Ticker | RDY |
| Exchange / Market | NYSE |
| Instrument type | ADR |
| Quote currency | USD |
Business
Dr. Reddy's is a global pharmaceutical company focused on generics, biosimilars, APIs and branded formulations, with the United States as its largest market followed by India, Russia/CIS and Europe.
Sector: Health Care — Pharmaceuticals
Earnings Context
Dr. Reddy's reports quarterly results (Indian fiscal year, April–March). US generics pricing, new product launches and regulatory (US FDA) updates are the most watched drivers.
ADR Structure
Dr. Reddy's Laboratories Ltd trades on a US exchange as an American Depositary Receipt, where a depositary bank holds the underlying Indian shares and issues dollar-denominated receipts against them. Each ADR represents a fixed ratio of underlying shares, so the price tracks the Indian listing adjusted for USD/INR. ADR programmes are SEC-registered and follow US disclosure rules.
Trading Hours
Dr. Reddy's Laboratories Ltd trades 07:00 PM to 01:30 AM IST (09:30 AM–04:00 PM US Eastern; one hour later during US winter), Monday to Friday. Outside those hours this page shows the last traded level, with change figures measured against the previous official close. All session times are expressed in Indian Standard Time (IST).
How to Read Dr. Reddy's Laboratories Ltd
Market participants often compare Dr. Reddy's Laboratories Ltd's US-session move with the previous NSE close of the underlying stock ahead of the next Indian open. The ADR premium or discount to the local listing reflects demand from international investors. US market sentiment and USD/INR both feed into the receipt's price.
52-week range: 11.36 – 15.67.
